“Probable Reversible Encephalopathy With Ceftazidime Avibactam and Aztreonam: A Case Report”. Asian Journal of Pharmaceutical and Health Sciences 16, no. 2 (June 30, 2026): 3283–3287. Accessed July 2, 2026. https://ajphs.com/index.php/ajphs/article/view/720.